Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: Implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels
2006 ◽
Vol 60
(3)
◽
pp. 389-393
◽
2012 ◽
Vol 159B
(7)
◽
pp. 850-858
◽
2016 ◽
Vol 77
(07)
◽
pp. e855-e859
◽
2008 ◽
Vol 9
(2)
◽
pp. 126-134
◽
2009 ◽
Vol 66
(7)
◽
pp. 674-680
◽
2009 ◽
Vol 150B
(8)
◽
pp. 1050-1062
◽
2018 ◽
Vol 79
(1)
◽
pp. 17l11824
◽
2003 ◽
Vol 73
(2)
◽
pp. 370-376
◽